Radiology Devices; Reclassification of Digital Breast Tomosynthesis System · Electoral Command Center

The Food and Drug Administration (FDA) is proposing to reclassify digital breast tomosynthesis (DBT) systems, product code OTE, which are postamendments class III devices, from cl…